The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá

Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utili...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24045
Acceso en línea:
https://doi.org/10.1080/14737167.2017.1246185
https://repository.urosario.edu.co/handle/10336/24045
Palabra clave:
Colombia
Comorbidity
Cross-sectional study
Family
Human
Human immunodeficiency virus
Major clinical study
Medical record
Model
Multiple regression
Nonhuman
Outpatient department
Quality of life
Statistical significance
Adult
Ambulatory care
Colombia
Comorbidity
Economics
Female
Health care cost
HIV Infections
Male
Middle aged
Pathophysiology
Regression analysis
Adult
Ambulatory Care
Colombia
Comorbidity
Cross-Sectional Studies
Female
Health Care Costs
HIV Infections
Humans
Male
Middle Aged
Quality of Life
Regression Analysis
Acquired Immune Deficiency Syndrome (AIDS)
Bogotá
Burden of disease
Colombia
Health-related quality of life (HRQOL)
Healthcare costs
Human Immunodeficiency Virus (HIV)
Patient and family costs
Utility
Rights
License
Abierto (Texto Completo)
id EDOCUR2_f5be8c02da6a4145e82964cc9df86659
oai_identifier_str oai:repository.urosario.edu.co:10336/24045
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 29363ce4-59b2-4f9b-b188-0f4a945abb51e19d8072-4e9c-4350-9626-4656e13e8ca94695e5f9-879b-4839-9847-af686bdc44d2cb8cc7a7-8221-43d7-baf9-ffc63f708c8b6758056600a4094b4c-2e49-4671-967b-9e95c2970256ba40f276-ab28-49e2-8d45-e21797e720062020-05-26T00:07:59Z2020-05-26T00:07:59Z2017Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utilities (EQ5D-5L) and HRQOL (EQ-VAS). CMs and other covariates were gathered from patient records. Multiple regression models were conducted to assess the impact of CMs. Results: Of all patients, 72% experienced CMs; of these, half experienced ?2 CMs (N = 49). CMs had a statistically significant impact on utilities when the EQ5D-5L (P = 0.022) was applied among patient with ?2 CMs. No statistical significance was found for the impact of CMs on costs. Conclusion: This study suggests that having multiple CMs significantly influences utility, and CMs have some impact on HRQOL measured using the EQ-VAS but this effect is at the border of significance. No significant impact was observed on costs. © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/14737167.2017.124618514737167https://repository.urosario.edu.co/handle/10336/24045engTaylor and Francis Ltd310No. 3303Expert Review of Pharmacoeconomics and Outcomes ResearchVol. 17Expert Review of Pharmacoeconomics and Outcomes Research, ISSN:14737167, Vol.17, No.3 (2017); pp. 303-310https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992413355&doi=10.1080%2f14737167.2017.1246185&partnerID=40&md5=d93dae38b6561d4e73efb09d0122d839Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURColombiaComorbidityCross-sectional studyFamilyHumanHuman immunodeficiency virusMajor clinical studyMedical recordModelMultiple regressionNonhumanOutpatient departmentQuality of lifeStatistical significanceAdultAmbulatory careColombiaComorbidityEconomicsFemaleHealth care costHIV InfectionsMaleMiddle agedPathophysiologyRegression analysisAdultAmbulatory CareColombiaComorbidityCross-Sectional StudiesFemaleHealth Care CostsHIV InfectionsHumansMaleMiddle AgedQuality of LifeRegression AnalysisAcquired Immune Deficiency Syndrome (AIDS)BogotáBurden of diseaseColombiaHealth-related quality of life (HRQOL)Healthcare costsHuman Immunodeficiency Virus (HIV)Patient and family costsUtilityThe impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in BogotáarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Van Duin, Mark JMConde, RafaelWijnen, BenEvers, Silvia MAAGonzález Rodríguez, Javier LeonardoGovers, Mark JGHiligsmann, Mickaël10336/24045oai:repository.urosario.edu.co:10336/240452022-05-02 07:37:16.218547https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
title The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
spellingShingle The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
Colombia
Comorbidity
Cross-sectional study
Family
Human
Human immunodeficiency virus
Major clinical study
Medical record
Model
Multiple regression
Nonhuman
Outpatient department
Quality of life
Statistical significance
Adult
Ambulatory care
Colombia
Comorbidity
Economics
Female
Health care cost
HIV Infections
Male
Middle aged
Pathophysiology
Regression analysis
Adult
Ambulatory Care
Colombia
Comorbidity
Cross-Sectional Studies
Female
Health Care Costs
HIV Infections
Humans
Male
Middle Aged
Quality of Life
Regression Analysis
Acquired Immune Deficiency Syndrome (AIDS)
Bogotá
Burden of disease
Colombia
Health-related quality of life (HRQOL)
Healthcare costs
Human Immunodeficiency Virus (HIV)
Patient and family costs
Utility
title_short The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
title_full The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
title_fullStr The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
title_full_unstemmed The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
title_sort The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
dc.subject.keyword.spa.fl_str_mv Colombia
Comorbidity
Cross-sectional study
Family
Human
Human immunodeficiency virus
Major clinical study
Medical record
Model
Multiple regression
Nonhuman
Outpatient department
Quality of life
Statistical significance
Adult
Ambulatory care
Colombia
Comorbidity
Economics
Female
Health care cost
HIV Infections
Male
Middle aged
Pathophysiology
Regression analysis
Adult
Ambulatory Care
Colombia
Comorbidity
Cross-Sectional Studies
Female
Health Care Costs
HIV Infections
Humans
Male
Middle Aged
Quality of Life
Regression Analysis
Acquired Immune Deficiency Syndrome (AIDS)
Bogotá
Burden of disease
Colombia
Health-related quality of life (HRQOL)
Healthcare costs
Human Immunodeficiency Virus (HIV)
Patient and family costs
Utility
topic Colombia
Comorbidity
Cross-sectional study
Family
Human
Human immunodeficiency virus
Major clinical study
Medical record
Model
Multiple regression
Nonhuman
Outpatient department
Quality of life
Statistical significance
Adult
Ambulatory care
Colombia
Comorbidity
Economics
Female
Health care cost
HIV Infections
Male
Middle aged
Pathophysiology
Regression analysis
Adult
Ambulatory Care
Colombia
Comorbidity
Cross-Sectional Studies
Female
Health Care Costs
HIV Infections
Humans
Male
Middle Aged
Quality of Life
Regression Analysis
Acquired Immune Deficiency Syndrome (AIDS)
Bogotá
Burden of disease
Colombia
Health-related quality of life (HRQOL)
Healthcare costs
Human Immunodeficiency Virus (HIV)
Patient and family costs
Utility
description Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utilities (EQ5D-5L) and HRQOL (EQ-VAS). CMs and other covariates were gathered from patient records. Multiple regression models were conducted to assess the impact of CMs. Results: Of all patients, 72% experienced CMs; of these, half experienced ?2 CMs (N = 49). CMs had a statistically significant impact on utilities when the EQ5D-5L (P = 0.022) was applied among patient with ?2 CMs. No statistical significance was found for the impact of CMs on costs. Conclusion: This study suggests that having multiple CMs significantly influences utility, and CMs have some impact on HRQOL measured using the EQ-VAS but this effect is at the border of significance. No significant impact was observed on costs. © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:07:59Z
dc.date.available.none.fl_str_mv 2020-05-26T00:07:59Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1080/14737167.2017.1246185
dc.identifier.issn.none.fl_str_mv 14737167
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24045
url https://doi.org/10.1080/14737167.2017.1246185
https://repository.urosario.edu.co/handle/10336/24045
identifier_str_mv 14737167
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 310
dc.relation.citationIssue.none.fl_str_mv No. 3
dc.relation.citationStartPage.none.fl_str_mv 303
dc.relation.citationTitle.none.fl_str_mv Expert Review of Pharmacoeconomics and Outcomes Research
dc.relation.citationVolume.none.fl_str_mv Vol. 17
dc.relation.ispartof.spa.fl_str_mv Expert Review of Pharmacoeconomics and Outcomes Research, ISSN:14737167, Vol.17, No.3 (2017); pp. 303-310
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992413355&doi=10.1080%2f14737167.2017.1246185&partnerID=40&md5=d93dae38b6561d4e73efb09d0122d839
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Taylor and Francis Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390629635391488